Literature DB >> 11861505

Aurintricarboxylic acid induces a distinct activation of the IGF-I receptor signaling within MDA-231 cells.

Michal Haimsohn1, Rachel Beery, Avraham Karasik, Hannah Kanety, Avraham Geier.   

Abstract

Aurintricarboxylic acid (ATA), a polymeric carboxylated triphenylmethane derivate, prevents apoptotic death in a variety of cell systems. Recently, we have shown that the survival promoting effect of ATA is transduced via activation of the IGF-I receptor (IGF-IR) signaling pathway. In breast cancer MDA-231 cells exposed either to the protein synthesis inhibitors cycloheximide or ricin or to the anticancer drug adriamycin, we have found that ATA, but not IGF-1, is a powerful antiapoptotic agent. The purpose of this study was to compare the ability of ATA and IGF-I to activate the IGF-IR signaling cascade and to correlate this ability to their survival potency. MDA-231 cells were exposed to ATA or IGF-I, up to 7 h, and the dynamics of activation of the IGF-IR signaling cascade was evaluated. Our results show that: 1) The amount of tyrosine phosphorylated IGF-IR proteins was greater after exposure to ATA, compared with IGF-I. 2) Two phosphorylated IGF-IR beta-subunits (a 95-kDa and a 75-kDa) were induced after exposure to ATA, whereas IGF-1 induced only the 95-kDa form. Immunoprecipitation of both receptor forms by antibodies against the alpha-subunit and against the carboxy terminus of the beta-subunit of the IGF-IR suggests that the 75-kDa form could be the beta-chain truncated at the amino terminus above the alpha-beta disulphide bridges. 3) The ATA-activated IGF-IR forms underwent slow dephosphorylation, compared with a rapid dephosphorylation of the IGF-I activated receptor. 4) The insulin receptor substrate-1/2-associated PI3K, Shc proteins, and the kinases Akt and Erk1/2, downstream mediators of the antiapoptotic signaling by IGF-IR, were activated to a higher extent and for a longer time period by ATA, compared with IGF-I. Taken together, the sustained activation of the IGF-IR signaling pathway by ATA may explain its stronger antiapoptotic effect. We suggest that this enhanced activity, and the different susceptibility of the IGF-IR to certain proteases and phosphatases, may indicate a distinct conformation of the ATA-activated IGF-IR.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11861505     DOI: 10.1210/endo.143.3.8681

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

1.  Aurintricarboxylic acid inhibits the early stage of vaccinia virus replication by targeting both cellular and viral factors.

Authors:  Chad Myskiw; Yvon Deschambault; Kristel Jefferies; Runtao He; Jingxin Cao
Journal:  J Virol       Date:  2006-12-27       Impact factor: 5.103

2.  Salutary effect of aurintricarboxylic acid on endotoxin- and sepsis-induced changes in muscle protein synthesis and inflammation.

Authors:  Lacee J Laufenberg; Abid A Kazi; Charles H Lang
Journal:  Shock       Date:  2014-05       Impact factor: 3.454

3.  Aurintricarboxylic acid is a potent inhibitor of influenza A and B virus neuraminidases.

Authors:  Anwar M Hashem; Anathea S Flaman; Aaron Farnsworth; Earl G Brown; Gary Van Domselaar; Runtao He; Xuguang Li
Journal:  PLoS One       Date:  2009-12-17       Impact factor: 3.240

4.  Aurintricarboxylic acid increases yield of HSV-1 vectors.

Authors:  Peter Pechan; Jeffery Ardinger; Jyothi Ketavarapu; Hillard Rubin; Samuel C Wadsworth; Abraham Scaria
Journal:  Mol Ther Methods Clin Dev       Date:  2014-02-19       Impact factor: 6.698

5.  Identification of potent inhibitors of arenavirus and SARS-CoV-2 exoribonucleases by fluorescence polarization assay.

Authors:  Sergio Hernández; Mikael Feracci; Carolina Trajano De Jesus; Priscila El Kazzi; Rafik Kaci; Laura Garlatti; Clemence Mondielli; Fabrice Bailly; Philippe Cotelle; Franck Touret; Xavier de Lamballerie; Bruno Coutard; Etienne Decroly; Bruno Canard; François Ferron; Karine Alvarez
Journal:  Antiviral Res       Date:  2022-06-16       Impact factor: 10.103

6.  Inhibition of Orbivirus Replication by Aurintricarboxylic Acid.

Authors:  Celia Alonso; Sergio Utrilla-Trigo; Eva Calvo-Pinilla; Luis Jiménez-Cabello; Javier Ortego; Aitor Nogales
Journal:  Int J Mol Sci       Date:  2020-10-02       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.